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Abstract
Objectives—The magnitude, characteristics, and morbidity of term (≥37 weeks gestation) 
newborns that are small-for-gestational-age (SGA) in the U.S. are underexplored. We sought to 
examine characteristics and trends for SGA-coded term newborns in the U.S.
Methods—Data were obtained from the Nationwide Inpatient Sample, a nationally representative 
database of hospital stays in the U.S. from 2002 to 2011. Term, singleton newborns with SGA 
codes were identified and examined over the study period. Demographic characteristics were 
compared for term newborns according to presence of SGA codes using χ2 tests. Odds ratios (OR) 
were calculated to compare morbidities between the two groups, adjusting for relevant 
demographic and clinical variables.
Results—In 2011, 15 per 1000 term newborns in the U.S. were coded as SGA, a 29.9 % increase 
since 2002. Compared with other term newborns, SGA term newborns were significantly (p < 
0.05) more likely to be female, receive public insurance, and reside in lower income zip codes. 
Comorbidities, including perinatal complications, metabolic disorders, central nervous system 
diseases, infection, and neonatal abstinence syndrome were more common among SGA-coded 
term newborns. These newborns also had higher odds of in-hospital death (OR = 3.0 95 % 
confidence interval: 2.0, 4.4), longer mean length of stay (3.7 vs. 2.3 days, p <0.001), and higher 
mean hospital charges ($12,621 vs. $5012, p < 0.001).
Conclusions for practice—Term newborns coded as SGA have higher morbidity, mortality, 
and incur higher hospital charges than other term newborns. More research is needed to 
understand causes of SGA so its incidence and effects can be reduced.
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Introduction
The neonatal period carries higher morbidity and mortality than the rest of infancy and 
childhood combined (McCormick 1985; Hamilton et al. 2013). It is thus important to 
identify populations of newborns at high risk for adverse outcomes. Two important measures 
associated with neonatal outcomes are gestational age and birthweight (McCormick 1985; 
Hamilton et al. 2013). While the importance of premature birth for neonatal morbidity and 
mortality is well-characterized, the influence of low birthweight independent of prematurity 
is less so (Wilcox 2001; Malin et al. 2014). Another measure used in clinical practice, based 
on gestational age and birthweight, is “small for gestational age” (SGA).
SGA is variously defined using growth curves and/or observed clinical characteristics, 
including fundal height, various body proportions, soft tissue measurements, and others 
(Chard et al. 1992; Lubchenco et al. 1966; Campbell and Thoms 1977; Clayton et al. 2007; 
Belizan et al. 1978; Hadlock et al. 1983; Weiner and Robinson 1989; Gardeil et al. 1999). 
<10th, <5th and <3rd percentile birthweight for gestational age are commonly used in 
research addressing this issue, although there are no standards directing physicians or coders 
to use a specific birthweight percentile cutoff to diagnose newborns as SGA and coded as 
such in the medical record (Malin et al. 2014; McIntire et al. 1999; Kristensen et al. 2007; 
Ananth and Vintzileos 2009). In preterm infants, SGA was originally considered an 
adaptation to a stressful intrauterine environment (Gluck and Kulovich 1973; Usher 1970) 
and protective against morbidity and mortality (Warshaw 1985; Yoon et al. 1980), a view 
that has changed over the years (McIntire et al. 1999; Bernstein et al. 2000; Grisaru-
Granovsky et al. 2012; Katz et al. 2013; Paranjothy et al. 2013). The existing data on the 
effects of SGA in infants born at ≥37 weeks are contradictory (Malin et al. 2014; Blair 1994; 
Minior and Divon 1998). It has been argued that as gestational age increases, the proportion 
of infants who experience pathological slow growth, or “intrauterine growth restriction” 
(IUGR), decreases, while the proportion who are constitutionally small, and not at increased 
risk of morbidity, increases (Ananth and Vintzileos 2009). Nevertheless, some studies have 
shown increased morbidity and mortality among term SGA infants, especially when using 
more restrictive cutoff points than the commonly used <10th percentile (McIntire et al. 
1999; Kristensen et al. 2007). There are many gaps in our knowledge about the 
characteristics and morbidity of term SGA newborns, including how best to differentiate 
between pathologically and constitutionally small newborns, demographic characteristics, 
associated morbidities experienced, and how these characteristics and morbidities are 
changing over time, if at all.
In this study we examine the burden suffered by newborns coded as SGA among a 
nationally representative sample of full term newborns in the U.S. We estimate what 
percentage of newborns receive an SGA code, and describe the distribution and 
demographic characteristics of term birth hospitalizations with these codes over 10 years 
(2002–2011) in the U.S. In addition, we compared morbidity outcomes, in-hospital deaths, 
length of hospital stay (LOS) and hospital charges between term newborns with and without 
SGA codes, and examined the trends of these parameters over time.
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Methods
Study Design
This is a retrospective, serial, cross-sectional analysis of a nationally representative sample 
of term (≥37 weeks of gestation) newborns with SGA codes, compared with term newborns 
without SGA codes in the United States from 2002 to 2011.
Data Source
We used hospital discharge data obtained from the Health-care Cost and Utilization Project 
(HCUP) Nationwide Inpatient Sample (NIS). The HCUP NIS is a nationally representative, 
all-payer database of hospital discharges from a 20 % probability sample of U.S. community 
hospitals, defined by the American Hospital Association as non-federal, short-term (average 
length of stay <30 days) general and specialty hospitals whose facilities are open to the 
public (HCUP 2011). The hospitals are stratified according to five criteria: geographic 
region, rural/urban location, number of beds, teaching status, and ownership. All discharge 
records from each selected hospital for the year in question are included in the NIS sample. 
The sample is weighted to allow the creation of nationally representative estimates. The 10 
years of NIS data we used in this analysis (2002–2011) contain 7,736,756 records from 
more than 1000 hospitals, and when weighted represent 37,568,326 live, singleton, term 
births.
The discharge records in the NIS database contain administrative data, including 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
diagnostic codes, procedure codes, length of stay (LOS), discharge disposition, and hospital 
charges. In this analysis, SGA is classified according to ICD-9-CM codes that are in turn 
based on medical providers’ diagnoses (Medicare Cf, Services M 2011). Birthweight is not 
available in the HCUP NIS; neither are the specific criteria used by medical providers to 
make their diagnoses.
During the period analyzed—2002 to 2011—the NIS underwent several revisions. Relevant 
to this analysis is the modification of the zip code income variable. In 2002, this variable is 
defined in relation to the poverty level. For 2003 and later, the zip code income variable is a 
quartile classification of the estimated median household income of residents in the patient’s 
ZIP Code (HCUP 2014). To avoid using differently defined variables, zip code income 
results for 2003, instead of 2002, are presented for comparison of 2002 to the other 3 years 
analyzed. This study was considered exempt from IRB review because it utilized de-
identified data.
Population
The individual unit of analysis in the NIS database is the discharge record, and we restricted 
to only those records indicating a live singleton birth. To accomplish this we included only 
infants with an ICD-9-CM code of V30, and excluded infants with any code indicative of 
multiple births (V31–V39). This allowed the selection of unique events, birth 
hospitalizations, while limiting double counting of individuals and excluding multiple births 
and stillbirths. Due to this selection method, post-transfer data are not available for 
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newborns who were transferred to another facility after birth. To limit the sample to term 
live births, newborns classified as preterm (ICD-9-CM codes 362.20, 362.22–362.27, 
765.00–765.19, 765.20–765.28) were excluded. ICD-9-CM codes that indicated a 
birthweight <1500 g (ICD-9-CM codes V21.31, V21.32, V21.33, 764.01–764.05, 764.11–
764.15, 764.21–764.25, 764.91–764.95) were also excluded due to the high likelihood of 
misclassification.
SGA newborns were defined through the use of the 764 series of ICD-9-CM codes (“Light-
for-dates infant without mention of fetal malnutrition,” “Light-for-dates infant with signs of 
fetal malnutrition,” “Fetal malnutrition without mention of light-for-dates,” and “Fetal 
growth retardation unspecified”).
Comorbidities and Procedures
We used ICD-9-CM codes to identify the following select morbidities and procedures: (1) 
birth trauma, including hypoxia and asphyxia (ICD-9-CM codes 767, 768); (2) seizures, 
central nervous system (CNS) diseases and feeding disorders (ICD-9-CM codes 779.0–779. 
3); (3) perinatal complications, including maternal conditions and complications, and 
complications of the placenta, cord and amniotic membranes (ICD-9-CM codes 760–763); 
(4) congenital anomalies (ICD-9-CM codes 740–759, 795.2, V13.6); (5) metabolic disorders 
(ICD-9-CM code 775), including (6) neonatal hypoglycemia (ICD-9-CM code 775.6); (6) 
neonatal abstinence syndrome (NAS) (ICD-9-CM code 779.5); (8) respiratory distress and 
other respiratory conditions (ICD-9-CM codes 769, 770); (9) congenital and neonatal 
infections (ICD-9-CM codes 771.0–771.89); (10) cesarean delivery (ICD-9-CM code 
V30.01); (11) and endotracheal intubation and continuous positive airway pressure (CPAP) 
(ICD-9-CM procedure codes 96.04, 96.05, 93.90–93.91, 96.7).
Data Analysis
Demographic, morbidity, discharge status (including inhospital death) and hospitalization 
data for 2002 and 2011 provided by HCUP were used to produce descriptive statistics 
describing the term SGA-coded and non-SGA-coded populations. To compare to the total 
number of term newborns in the United States classified as SGA according to a birthweight 
percentile cutoff, the total number of term births with SGA codes in HCUP were expressed 
as a proportion of <3rd percentile SGA term births identified in CDC Vital Records data 
(National Center for Health Statistics 2011), calculated using growth curves based on recent 
(1998–2006) U.S. data from 33 states (Olsen et al. 2010).
We used χ2 tests to compare the proportional distributions of term SGA coded newborns 
with term non-SGA coded newborns according to the following variables: sex, expected 
primary payer, urban or rural location of the hospital, geographic region of the hospital, zip 
code income quartile and disposition of the patient. We also calculated total and mean length 
of stay (LOS), and total and mean hospital charges associated with the hospitalization; 
means for the two groups were compared using Student’s t tests. Rates of morbidities per 
1000 term births were calculated for 2002 and 2011, and compared according to presence of 
SGA diagnosis using multivariable logistic regression, adjusting for sex, expected primary 
payer, mode of delivery and presence of congenital anomalies. To assess trends in 
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morbidities, hospital charges, and LOS among the SGA coded and non-SGA coded groups, 
the change in outcome per year from 2002 to 2011 was calculated using multivariable 
logistic and multiple linear regressions for binary and continuous outcomes, respectively, 
adjusting for sex, expected primary payer and presence of congenital anomalies. All 
statistical analyses were carried out using survey procedures SAS 9.3 and replicated with 
SAS callable SUDAAN (SAS Institute, Cary NC), which use the weights and the 
stratification and cluster variables provided by HCUP to account for the sample design when 
calculating variances.
As a sensitivity analysis, we produced crude odds ratios for the relationships between SGA 
and the outcomes studied corrected for various levels of SGA misclassification(Greenland 
1996) as follows: (1) high specificity (99 %) and misclassification due to non-differential 
low sensitivity (from 95 to 30 %); (2) high sensitivity (95 %) and differential 
misclassification due to low sensitivity (95 to 30 %) only among those who did not suffer 
from the outcomes studied.
To estimate costs associated with the hospitalization, we used year-specific Cost-to-Charge 
Ratios (CCR) provided by the Agency for Healthcare Research and Quality using data from 
the Centers for Medicare and Medicaid Services (Friedman et al. 2001). Hospital-specific 
CCRs—the availability of which increased from 67 % of hospitals in 2002 to 88 % in 2011
—were used where possible. When unavailable, the weighted group average CCR was used, 
where group was defined based on state, urban/rural, investor owned/other, and number of 
beds. All charges and costs are expressed in 2011 dollars.
Results
In 2002 and 2011, respectively, there were an estimated 44,161 and 51,956 birth 
hospitalizations of singleton, term newborns with SGA codes. These comprised 12 per 1000 
hospital term births (2002) and 15 per 1000 hospital term births (2011) (Fig. 1). In 2011, the 
51,956 SGA coded term births identified in HCUP data is approximately half as large as the 
total number of <3rd percentile births in CDC Vital Records data (101,329).
In 2011, SGA-coded term newborns were more likely to be female, have public insurance, 
and reside in the lowest zip income quartile areas than their non-SGA-coded counterparts 
(Table 1). The distribution of term births by hospital location (urban/rural) and geographic 
region was not significantly different according to coded SGA status. SGA-coded term 
newborns were also more likely to have been delivered by cesarean delivery, and were more 
likely to die during the birth hospitalization or to be transferred or have other non-routine 
dispositions.
Hospital charges were significantly higher, and length of stay significantly longer, for SGA-
coded, compared with non-SGA-coded term newborns. In 2011, mean length of stay for 
birth hospitalizations of SGA-coded term newborns was 3.7 versus 2.3 days for non-SGA 
coded term newborns, and mean hospital charges were $12,621 versus $5013 for term 
newborns with and without SGA diagnosis, respectively. Hospital costs in 2011 for SGA 
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coded term newborns ($3753) were also higher than for non-SGA-coded term newborns 
($1489).
SGA term newborns had consistently higher odds of having several comorbidities, even after 
adjusting for sex, expected primary payer, mode of delivery and presence of congenital 
anomalies. Birth trauma was the only comorbidity investigated for which there was no 
difference in odds between term newborns with and without SGA codes (Table 2). During 
2002 and 2011, the comorbidities with the greatest magnitudes of association with SGA 
diagnosis were seizures/CNS diseases/feeding disorders, metabolic disorders and NAS 
(Table 2). SGA diagnosis was also strongly associated with perinatal complications, 
congenital anomalies, respiratory distress and other respiratory conditions, congenital/
neonatal infections, and intubation and CPAP procedures, and with in-hospital mortality, 
with adjusted odds ratios (ORs) of 1.9 or larger. These associations persisted for each of our 
study years (data from interim years not shown).
Trends Over Time
The number of SGA-coded term newborn hospitalizations increased from 2002 to 2011 
(Table 3), even though CDC vital records did not show a corresponding increase in births 
<3rd percentile for gestational age. Among SGA-coded term newborns, two comorbidities 
showed consistent and significant increases over the study period: neonatal abstinence 
syndrome and congenital anomalies. Odds of these comorbidities also increased among non-
SGA coded term newborns and these increases did not differ significantly according to 
presence of SGA diagnosis. Odds of metabolic disorders increased among term newborns 
without SGA codes, but did not for those with SGA codes. Rates of select outcomes over the 
study period are presented in Fig. 2.
Over the study period, adjusted mean hospital charges for SGA-coded term newborns 
increased by 40 %, from $8714 in 2002 to $12,242 in 2011; those of the non-SGA group 
increased by 57 %, from $3125 in 2002 to $4906 in 2011 (Table 3). Costs, however, did not 
significantly increase for either group over the study period (data not shown).
Discussion
There is a paucity of evidence on the disease burden associated with term SGA births, as 
well as their distribution and characteristics nationally. A study that used data from the 2001 
HCUP NIS dataset estimated that there were 58,600 delivery discharges with ICD-9-CM 
codes indicating slow fetal growth/malnutrition; these births had longer stays and 
significantly higher costs than for uncomplicated newborn hospitalizations (Russell et al. 
2007). However, that study did not limit the analysis to term infants (Escobar et al. 2006, 
2005).
Term births with SGA codes result in a disproportionate economic burden (6.5 % of all 
charges and 3.5 % of all costs for term births). In 2011, hospital charges for these births 
were, on average, more than double those of those without SGA codes. These charges are 
increasing over time, possibly reflecting the overall trend of hospital charges in the United 
States over the study period (Weiss et al. 2014). Estimated costs did not increase over that 
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period, although this dataset does not provide information on what hospitals were actually 
reimbursed for the services they provided. In addition to the increased charges, families and 
hospital systems must accommodate the increased time that SGA-coded term newborns 
spend in the hospital and increased odds of in-hospital mortality (5.1 % of total term 
newborn deaths).
We found that there are differences in the distribution of term births with SGA codes in the 
U.S. by income. These births were more frequent among the lowest socioeconomic (SES) 
stratum, as evidenced by both proxy measures of SES used: expected primary payer and zip 
code income quartile. On the contrary, there was no significant variation in the distribution 
of births with SGA codes by US geographic region or urban/rural location. This contrasts 
with the findings of a 2005 study that showed that rates of low birthweight varied regionally 
in the U.S. (Thompson et al. 2005); that analysis used smaller geographical units than those 
available in the HCUP NIS (Healthcare Cost and Utilization Project (HCUP) 2014).
SGA diagnosis was associated with several neonatal comorbidities among term newborns. 
These comorbidities may influence and/or be influenced by the processes that result in a 
term SGA birth. Of interest, there was a strong association of SGA diagnosis with NAS. 
Evidence suggests maternal drug use may be associated with both premature and SGA birth 
(Cleary et al. 2011). There have recently been increases in the number of prescription opioid 
overdoses (Centers for Disease Control and Prevention 2013) and newborns with NAS 
(Patrick et al. 2012). A study using the HCUP NIS found an 11.9 % increase in maternal 
opioid use among pregnancy hospitalizations over a period significantly overlapping the one 
studied in our analysis (2001–2009) (Salihu et al. 2015). SGA diagnosis was also associated 
with congenital anomalies in this study, a comorbidity that was increasingly coded over the 
study period. This increase may be due to enhanced detection via prenatal and neonatal 
screening (Siddique et al. 2009; Marek et al. 2011). The other categories of co-morbidities 
that exhibited associations of large magnitude with SGA diagnosis included seizures/CNS 
diseases/feeding disorders and metabolic disorders. The strength of these associations may 
be due in part to potential shared risk factors leading to their causation. These co-morbidities 
have been included to provide a comprehensive picture of the disease burden faced by term 
newborns with SGA codes. It is important to note that none of the comorbidities that were 
increasingly prevalent for SGA-coded term newborns increased more rapidly than for non-
SGA-coded term newborns. Indeed, for metabolic disorders, which increased for the non-
SGA group, there was no increase in the SGA group. This last may indicate improving 
management of pregnancies and deliveries of infants with SGA diagnosis, but may also be a 
result of more thorough coding practices over time.
In the most recent year we studied (2011), SGA-coded term newborns had a 200 % higher 
odds of in-hospital death than non-SGA-coded term newborns. A study that used a linked 
birth/infant death dataset from the CDC National Center for Health Statistics showed SGA 
infants born at term from 1995 to 1999 had a 50 % higher odds of overall infant mortality, 
and 20 % higher odds of neonatal death compared to term non-SGA infants (Kristensen et 
al. 2007). The smaller increased odds in that study, compared with our study, likely stems 
from its adjustment for a wide range of maternal factors. Another study showed term 
newborns born at <3rd percentile birthweight for their gestational age had a higher neonatal 
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mortality rate compared with non-SGA newborns (McIntire et al. 1999). Additionally, a 
recent systematic review showed higher odds of neonatal mortality for SGA (defined as 
<10th percentile birthweight for gestational age) infants, but did not analyze term births 
separately (Malin et al. 2014; Wennergren et al. 1988).
SGA newborns are a heterogeneous group. As noted by other researchers, definitions of 
SGA based on birthweight quantiles are a mix of constitutionally small and pathologically 
small newborns (Wilcox 2001; Malin et al. 2014; McIntire et al. 1999; Ananth and 
Vintzileos 2009). Results from this study are representative of newborns diagnosed and 
coded as SGA, but should not necessarily be applied to specific birthweight for gestational 
age quantiles. The comparison of term SGA newborns in the HCUP NIS with those in 
National Vital Records data used a <3rd birth-weight percentile cutpoint because term 
newborns under this cutpoint have been shown to have significantly worse outcomes 
compared to their normal birthweight peers (McIntire et al. 1999). The estimated number of 
term newborns with SGA diagnoses is considerably smaller than what would have been 
expected had birthweight for gestational age percentiles been used to define exposure. Term 
newborns with SGA codes increased over the study period without an accompanying 
increase in term SGA births identified using a 3rd percentile for gestational age cutoff. The 
increase in the NIS likely results from increased coding of the condition.
Newborns with SGA codes may represent neonates with more pronounced growth 
restriction, or with other comorbidities. This would tend to bias associations away from the 
null hypothesis, when compared to an exposure group based on a 3rd or 10th percentile 
birthweight per gestational age cutoff. Analyses correcting for differential misclassification 
due to lower (30 %) sensitivity of SGA coding among those without adverse outcomes 
weakened associations between coded SGA and the outcomes, but most ORs remained 
elevated compared to term newborns without SGA codes.
To our knowledge, this is the first study to produce national estimates of the number of 
SGA-coded term births in the U.S., as well as their distribution, demographic and clinical 
characteristics, and trends over time. Strengths include the large sample size, and ability to 
produce nationally-representative estimates of perinatal and newborn outcomes, including 
hospital charge data. However, this study has some limitations. The maternal record cannot 
be linked to the newborn birth record, so the effect of maternal preconception and pregnancy 
factors such as maternal age, weight, tobacco use, prescription drug use, diabetes, and other 
parameters that may influence SGA cannot be assessed. This may also result in coding only 
for the more serious perinatal complications in the infant record, thus biasing away from the 
null hypothesis. Information on maternal race was not reliably available for all states or 
years (HCUP 2014). Analyses using administrative datasets like the NIS depend on the 
accuracy and completeness of coding, which may be variable and may change over time. 
Indeed, the fact that some conditions increased over time in both SGA and non SGA-coded 
newborns may suggest improvements in thoroughness of coding practices in the U.S., as 
well as increases in the number of diagnoses per record reported to HCUP by states. 
Restricting this study to the birth hospitalization means post-transfer data are not available 
for those requiring transfer to a different facility after birth, and thus underestimates the true 
costs of hospitalizations for term SGA births, as well as the burden of co-morbidities that 
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may require care at referral centers (such as newborn intensive care, cardiopulmonary 
support or care for neurologic diseases, to name a few). This may disproportionately affect 
those with SGA diagnosis, as they generally have more co-morbidities, biasing observed 
measures of disease burden closer to the null. However, this restriction assured that each 
hospitalization represented an individual newborn. In this analysis the non-SGA group 
included all term births without SGA diagnosis, whether appropriate for gestational age 
(AGA) or large for gestational age (LGA). However, the associations observed would only 
be expected to be larger if only AGA newborns had been in the comparison group. LGA 
newborns are known to be at increased risk for certain morbidities (Weissmann-Brenner et 
al. 2012), thus their inclusion may bias the adjusted odds ratios for such complications 
(particularly birth trauma or metabolic disorders, such as hypoglycemia) towards the null.
The results of this study reinforce the need for interventions to address factors associated 
with SGA, especially among populations shown to have higher prevalence of the condition. 
These can include interventions addressing established factors like maternal tobacco use and 
chronic hypertension. The rapid increase in the prevalence of neonatal abstinence syndrome 
in the context of increasing maternal opioid use and opioid overdoses coupled with the 
association shown between neonatal abstinence and SGA gives another reason to address 
this growing public health threat. Considering the higher charges term newborns coded SGA 
incur, interventions of this nature also have the potential to reduce the financial burden on 
individuals and public health insurance programs.
In conclusion, more newborns are being diagnosed as SGA in the U.S., both in numbers and 
as a percentage of all term births since 2002, possibly due to increased awareness. SGA-
coded term newborns are more likely than those without SGA codes to come from families 
with lower income, suffer an increased burden of morbidity, and experience longer, often 
more medically complex and costly birth hospitalizations. These findings call for further 
research to characterize and address the causes and associated morbidities of SGA among 
term newborns, as well as to identify ways to reduce SGA and its complications.
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Significance
What’s known on this topic
Size for gestational age is an important measure of neonatal health. Small for gestational 
age at term (≥37 weeks of gestational age) newborns are less well characterized, 
compared with preterm neonates.
What this study adds
Characteristics, morbidity, mortality and trends are described for newborns coded as 
small for gestational age at term in a nationally representative sample from 2002 to 2011.
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Fig. 1. 
Births with codes for small for gestational age per 1000 live, singleton term births per year, 
2002–2011
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Fig. 2. 
Annual rates (based on data from the Healthcare Cost and Utilization Project) of select 
outcomes per 1000 live, singleton term (≥ weeks of gestational age) births in the USA 2002–
2011. a Neonatal abstinence syndrome. b Congenital anomalies. c Metabolic disorders. d In-
hospital death
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